TITLE

Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial

AUTHOR(S)
Predy, Gerald N.; Goel, Vinti; Lovlin, Ray; Donner, Allan; Stitt, Larry; Basu, Tapan K.
PUB. DATE
October 2005
SOURCE
CMAJ: Canadian Medical Association Journal;10/25/2005, Vol. 173 Issue 9, p1043
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background Upper respiratory tract infections are a major source of morbidity throughout the world. Extracts of the root of North American ginseng (Panax quinquefolium) have been found to have the potential to modulate both natural and acquired immune responses. We sought to examine the efficacy of an extract of North American ginseng root in preventing colds. Methods We conducted a randomized, double-blind, placebo-controlled study at the onset of the influenza season. A total of 323 subjects 18-65 years of age with a history of at least 2 colds in the previous year were recruited from the general population in Edmonton, Alberta. The participants were instructed to take 2 capsules per day of either the North American ginseng extract or a placebo for a period of 4 months. The primary outcome measure was the number of Jackson-verified colds. Secondary variables measured included symptom severity, total number of days of symptoms and duration of all colds. Cold symptoms were scored by subjects using a 4-point scale. Results Subjects who did not start treatment were excluded from the analysis (23 in the ginseng group and 21 in the placebo group), leaving 130 in the ginseng group and 149 in the placebo group. The mean number of colds per person was lower in the ginseng group than in the placebo group (0.68 [standard deviation (SD) 0.82] v. 0.93 [SD 0.91], difference 0.25%, 95% confidence interval [CI] 0.04-0.45). The proportion of subjects with 2 or more Jackson-verified colds during the 4-month period (10.0% v. 22.8%, 12.8% difference, 95% CI 4.3-21.3) was significantly lower in the ginseng group than in the placebo group, as were the total symptom score (77.5 [SD 84.6] v. 112.3 [SD 102.5], difference 1.5%, 95% CI 1.2-2.0) and the total number of days cold symptoms were reported (10.8 [SD 9.7] v. 16.5 [SD 13.8] days, difference 1.6%, 95% CI 1.3-2.0) for all colds. Interpretation Ingestion of a poly-furanosyl-pyranosyl-saccharide-rich extract of the roots of North American ginseng in a moderate dose over 4 months reduced the mean number of colds per person, the proportion of subjects who experienced 2 or more colds, the severity of symptoms and the number of days cold symptoms were reported.
ACCESSION #
18599395

 

Related Articles

  • A rare anomaly: 'hemitruncus'. Jayan, J. P. Praveen; Vijayalakshmi, Ishwarappa B.; Narasimhan, Chitra // Heart;Jun2011, Vol. 97 Issue 12, p1027 

    The article examines the case of a 7-year-old boy with a history of frequent respiratory tract infections in infancy and was diagnosed of hemitruncus.

  • Upper Respiratory Tract Infection. Del Mar, Chris B. // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2143 

    Part I. Presents information on upper respiratory tract infections. Definition; Incidence; Risk factors.

  • Respiratory rite of passage visits this time every year. Powell, Dennis E. // Athens News;9/23/2013, p4 

    A personal narrative is presented which explores the author's experience of getting the fog disease, an unknown respiratory ailment.

  • Respiratory illness and home environment of ethnic groups. Melia, R.J.W.; Chinn, S.; Rona, R.J. // British Medical Journal (Clinical Research Edition);5/21/1988, Vol. 296 Issue 6634, p1438 

    Focuses on the prevalence of respiratory illness among ethnic groups in England. Enumeration of the factors differentiating the symptoms and diseases; Comparison on the prevalence of several conditions between Afro-Caribbeans and Asians; Explanation on the cause of the differences.

  • Efficacy of COLD-fX in the Prevention of Respiratory Symptoms in Community-Dwelling Adults: A Randomized, Double-Blinded, Placebo Controlled Trial. McElhaney, Janet E.; Goel, Vinti; Toane, Benjamin; Hooten, Johnathan; Shan, Jacqueline J. // Journal of Alternative & Complementary Medicine;Mar2006, Vol. 12 Issue 2, p153 

    Background: COLD-fX (CVT-E002), a proprietary extract of the roots of North American ginseng ( Panax quinquefolium), rich in poly-furanosyl-pyranosyl-saccharides, has been found efficacious in the prevention of respiratory infections in institutionalized seniors and healthy adults. Objective: We...

  • Intervention with educational outreach at large scale to reduce antibiotics for respiratory tract infections: a controlled before and after study. HM Smeets; MM Kuyvenhoven; AE Akkerman; I Welschen; GP Schouten; GA van Essen; TJM Verheij // Family Practice;Jun2009, Vol. 26 Issue 3, p183 

    Background. A multiple intervention targeted to reduce antibiotic prescribing with an educational outreach programme had proven to be effective in a randomized controlled trial in 12 peer review groups, demonstrating 12% less prescriptions for respiratory tract infections. Objective. To assess...

  • Human Metapneumovirus, Australia, 2001-2004. Sloots, Theo P.; Mackay, Ian M.; Bialasiewicz, Seweryn; Jacob, Kevin C.; McQueen, Emily; Harnett, Gerald B.; Siebert, David J.; Masters, I. Brent; Young, Paul R.; Nissen, Michael D. // Emerging Infectious Diseases;Aug2006, Vol. 12 Issue 8, p1263 

    We examined 10,025 respiratory samples collected for 4 years (2001-2004) and found a 7.1% average annual incidence of human metapneumovirus. The epidemic peak of infection was late winter to spring, and genotyping showed a change in predominant viral genotype in 3 of the 4 years.

  • Adult diagnosis of Swyer-James-MacLeod syndrome: a case report.  // Journal of Medical Case Reports;2011, Vol. 5 Issue 1, p1 

    The article presents a case study of a 53-year-old Caucasian woman with Swyer-James-MacLeod syndrome. It is noted that after evaluation for recurrent respiratory infections, this disorder is diagnosed mostly in childhood. It is mentioned that Swyer-James-MacLeod syndrome is associated with...

  • The role of airway stenting in pediatric tracheobronchial obstruction. Antón-Pacheco, Juan L.; Cabezalí, Daniel; Tejedor, Raquel; López, María; Luna, Carmen; Comas, Juan V.; de Miguel, Eduardo // European Journal of Cardio-Thoracic Surgery;Jun2008, Vol. 33 Issue 6, p1069 

    Abstract: Objective: Tracheobronchial obstruction is infrequent in the pediatric age group but it is associated with significant morbidity and mortality. The purpose of this study is to review the results of a single institution experience with endoscopic stent placement in children with benign...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics